NVAX Novavax Inc.

1.92
+0.02  (+1%)
Previous Close 1.9
Open 1.92
Price To Book -5.82
Market Cap 735072240
Shares 382,850,125
Volume 6,794,218
Short Ratio
Av. Daily Volume 9,649,414

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 immunogenicity and safety data data released January 3, 2019. Phase 3 trial to be initiated in 2019.
NanoFlu vaccine
Influenza
Phase 2 safety and immunogenicity data released July 24, 2017 - efficacy trial to be initiated 2018.
RSV F Vaccine immunogenicity trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 3 released September 15, 2016 did not demonstrate efficacy.
RSV vaccine - Resolve trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 2 data released September 15, 2016.
RSV F Vaccine rollover trial
Respiratory Syncytial Virus (RSV) in older adults
Phase 3 top-line data due 1Q 2019.
RSV vaccine - prepare trial
Respiratory Syncytial Virus (RSV) in healthy pregnant women - protect infants via maternal immunization
Further Phase 2 trials planned
Seasonal Influenza Vaccine
Seasonal Flu

Latest News

  1. Research Report Identifies Novavax, Zillow Group, Broadridge Financial Solutions, Summit Midstream Partners, LP, Primoris Services, and RE/MAX with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
  2. Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know
  3. Novavax (NVAX) Gains As Market Dips: What You Should Know
  4. Analyst: This Medical Stock Could Triple
  5. 4 Healthcare Stocks Looking For A Healthy Start On Monday (1/28/19)
  6. Why Short-Sellers Raised Their Bets Against 2 Surging Biotech Stocks
  7. A Biotech Play You Can't Afford To Miss
  8. 3 High-Growth Stocks That Could Soar
  9. Best Bottom Bouncing Opportunities
  10. Here's How Novavax Stock Gained 48.4% in 2018
  11. Today's Research Reports on Trending Tickers: Novavax and Allogene Therapeutics
  12. 3 Great Stocks Under $10
  13. Is Novavax (NVAX) Outperforming Other Medical Stocks This Year?
  14. Top 3 Healthcare Penny Stocks for 2018
  15. Novavax Rose Due to Positive NanoFlu Vaccine Results
  16. Why GameStop, Novavax, and Epizyme Jumped Today
  17. Novavax kicks off 2019 with positive flu vaccine trial results
  18. These 4 Healthcare Stocks Are Making Moves
  19. Why Novavax's Stock Is Surging Today
  20. Biotech Stocks Set to Start 2019 Off with a Bang

SEC Filings

  1. SC 13G - Statement of acquisition of beneficial ownership by individuals 19585288
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19583171
  3. 8-K - Current report 181259899
  4. 424B5 - Prospectus [Rule 424(b)(5)] 181259890
  5. CT ORDER - Confidential treatment order 181237303
  6. 8-K - Current report 181169950
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 181166799
  8. 8-K - Current report 181157380
  9. 8-K - Current report 181005340
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 181001848